CGP 6.78% 6.3¢ consegna group limited

not a one trick pony!

  1. 3,993 Posts.
    We are not a one trick pony.

    PRODUCT PORTFOLIO

    ON MARKET

    SPORTS - Turbine™
    » Turbine design complete and market ready;
    » Manufacturing partner secured;
    » Strong athlete endorsement & elite user trial;
    » Core target: males 20-50 years old across cycling, running, triathlons and aerobic sports initially;
    » A sophisticated international sports brand being built.

    IN DEVELOPMENT
    - ROLLOUT 2014 & BEYOND

    SLEEP– snoring & obstructive sleep apnea
    » Clear unmet needs;
    » Target males > 40 years plus;
    » Product design in progress for snoring & early stage sleep apnea;
    » Anticipated launch 2014.

    WELLBEING
    – nasal congestion, appetite suppressant, yoga/pilates
    » Fragrance trial 2014;
    » Yoga & pilates product roll out in 2014.

    DRUG DELIVERY
    – nasal medical delivery
    » Avoids current drug delivery issues;
    » Rapid uptake into blood stream;
    » Potential for patent extensions;
    » Potential treatment for sinus diseases and allergies;
    » First trial programme being defined – migraine.


    IP & TECHNOLOGY
    • A nasal dilator with ability to adjust the dilation on each side;
    • Comfortable and discrete to wear;
    • Made of medical grade polymer;
    • Nasal breathing facilitates parasympathetic nervous system (reduces anxiety, slows heart rate and reduces muscle tension);
    • 18 patents granted & pending in major jurisdictions;
    • Trademarks granted & pending;
    • Global manufacturing partner secured for development in all areas


    Clear milestones for next 6 months:
    • Deliver revenues with launch of sports
    product; the
    ‘Turbine’, November 2013;
    • Product development in snoring and
    well-being set for 2014 launch;
    • Clinical program: sleep apnea & drug
    delivery commence in 2014.
 
watchlist Created with Sketch. Add CGP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.